Douglas Nixon of the University of California at San Francisco will test his hypothesis that APOBEC proteins, which have been found to restrict replication of HIV, can be used to as an immunogen to stimulate a T cell response which would act against HIV infected cells.
Grant ID
OPP51950
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False